Applied Therapeutics Inc
NASDAQ:APLT

Watchlist Manager
Applied Therapeutics Inc Logo
Applied Therapeutics Inc
NASDAQ:APLT
Watchlist
Price: 9.625 USD 3.83% Market Closed
Market Cap: 1.1B USD
Have any thoughts about
Applied Therapeutics Inc?
Write Note

Intrinsic Value

The intrinsic value of one APLT stock under the Base Case scenario is 6.71 USD. Compared to the current market price of 9.625 USD, Applied Therapeutics Inc is Overvalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

APLT Intrinsic Value
6.71 USD
Overvaluation 30%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Applied Therapeutics Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for APLT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about APLT?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Applied Therapeutics Inc

Provide an overview of the primary business activities
of Applied Therapeutics Inc.

What unique competitive advantages
does Applied Therapeutics Inc hold over its rivals?

What risks and challenges
does Applied Therapeutics Inc face in the near future?

Has there been any significant insider trading activity
in Applied Therapeutics Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Applied Therapeutics Inc.

Provide P/S
for Applied Therapeutics Inc.

Provide P/E
for Applied Therapeutics Inc.

Provide P/OCF
for Applied Therapeutics Inc.

Provide P/FCFE
for Applied Therapeutics Inc.

Provide P/B
for Applied Therapeutics Inc.

Provide EV/S
for Applied Therapeutics Inc.

Provide EV/GP
for Applied Therapeutics Inc.

Provide EV/EBITDA
for Applied Therapeutics Inc.

Provide EV/EBIT
for Applied Therapeutics Inc.

Provide EV/OCF
for Applied Therapeutics Inc.

Provide EV/FCFF
for Applied Therapeutics Inc.

Provide EV/IC
for Applied Therapeutics Inc.

Show me price targets
for Applied Therapeutics Inc made by professional analysts.

What are the Revenue projections
for Applied Therapeutics Inc?

How accurate were the past Revenue estimates
for Applied Therapeutics Inc?

What are the Net Income projections
for Applied Therapeutics Inc?

How accurate were the past Net Income estimates
for Applied Therapeutics Inc?

What are the EPS projections
for Applied Therapeutics Inc?

How accurate were the past EPS estimates
for Applied Therapeutics Inc?

What are the EBIT projections
for Applied Therapeutics Inc?

How accurate were the past EBIT estimates
for Applied Therapeutics Inc?

Compare the revenue forecasts
for Applied Therapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Applied Therapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Applied Therapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Applied Therapeutics Inc compared to its peers.

Compare the P/E ratios
of Applied Therapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Applied Therapeutics Inc with its peers.

Analyze the financial leverage
of Applied Therapeutics Inc compared to its main competitors.

Show all profitability ratios
for Applied Therapeutics Inc.

Provide ROE
for Applied Therapeutics Inc.

Provide ROA
for Applied Therapeutics Inc.

Provide ROIC
for Applied Therapeutics Inc.

Provide ROCE
for Applied Therapeutics Inc.

Provide Gross Margin
for Applied Therapeutics Inc.

Provide Operating Margin
for Applied Therapeutics Inc.

Provide Net Margin
for Applied Therapeutics Inc.

Provide FCF Margin
for Applied Therapeutics Inc.

Show all solvency ratios
for Applied Therapeutics Inc.

Provide D/E Ratio
for Applied Therapeutics Inc.

Provide D/A Ratio
for Applied Therapeutics Inc.

Provide Interest Coverage Ratio
for Applied Therapeutics Inc.

Provide Altman Z-Score Ratio
for Applied Therapeutics Inc.

Provide Quick Ratio
for Applied Therapeutics Inc.

Provide Current Ratio
for Applied Therapeutics Inc.

Provide Cash Ratio
for Applied Therapeutics Inc.

What is the historical Revenue growth
over the last 5 years for Applied Therapeutics Inc?

What is the historical Net Income growth
over the last 5 years for Applied Therapeutics Inc?

What is the current Free Cash Flow
of Applied Therapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Applied Therapeutics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Applied Therapeutics Inc

Current Assets 104.6m
Cash & Short-Term Investments 99.1m
Receivables 262k
Other Current Assets 5.2m
Non-Current Assets 2m
PP&E 2m
Current Liabilities 99m
Accounts Payable 2.8m
Accrued Liabilities 13m
Other Current Liabilities 83.1m
Non-Current Liabilities 1.7m
Other Non-Current Liabilities 1.7m
Efficiency

Earnings Waterfall
Applied Therapeutics Inc

Revenue
10.4m USD
Operating Expenses
-146.3m USD
Operating Income
-135.8m USD
Other Expenses
-133.6m USD
Net Income
-269.4m USD

Free Cash Flow Analysis
Applied Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

APLT Profitability Score
Profitability Due Diligence

Applied Therapeutics Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional Revenue Growth Forecast
Exceptional ROE
ROE is Increasing
43/100
Profitability
Score

Applied Therapeutics Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

APLT Solvency Score
Solvency Due Diligence

Applied Therapeutics Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
48/100
Solvency
Score

Applied Therapeutics Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

APLT Price Targets Summary
Applied Therapeutics Inc

Wall Street analysts forecast APLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APLT is 13.056 USD with a low forecast of 11.11 USD and a high forecast of 14.7 USD.

Lowest
Price Target
11.11 USD
15% Upside
Average
Price Target
13.056 USD
36% Upside
Highest
Price Target
14.7 USD
53% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for APLT?

Click here to dive deeper.

Dividends

Applied Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for APLT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

APLT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Applied Therapeutics Inc Logo
Applied Therapeutics Inc

Country

United States of America

Industry

Biotechnology

Market Cap

1.1B USD

Dividend Yield

0%

Description

Applied Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 34 full-time employees. The company went IPO on 2019-05-09. The Company’s molecular target is aldose reductase (AR), an enzyme that converts glucose to sorbitol under oxidative stress conditions. Its product candidates include AT-007, AT-001, AT-003 and AT-104. The Company’s AT-007 is a central nervous system (CNS) penetrant ARI, which is developed for the treatment of galactosemia. AT-001 is an aldose reductase inhibitor (ARI) with exposure and nerve permeability. AT-001 is developed for the treatment of diabetic cardiomyopathy (DbCM), fatal fibrosis of the heart. Its AT-003 is an ARI designed to cross through the back of the eye when dosed orally. AT-003 is developed for the treatment of diabetic retinopathy (DR). AT-104 is a dual selective PI3K inhibitor in preclinical development for T Cell Acute Lymphoblastic Leukemia (T-ALL).

Contact

NEW YORK
New York City
545 5Th Avenue, Suite 1400
+12122209319.0
www.appliedtherapeutics.com

IPO

2019-05-09

Employees

34

Officers

Chair of the Board of Directors, Founder, President, CEO & Secretary
Dr. Shoshana Shendelman Ph.D.
Chief Medical Officer
Dr. Riccardo Perfetti M.D., Ph.D.
COO & Chief Business Officer
Mr. Constantine Chinoporos
Chief Accounting Officer
Ms. Catherine Thorpe
Chief Commercial Officer
Mr. Corwin Dale Hooks

See Also

Discover More
What is the Intrinsic Value of one APLT stock?

The intrinsic value of one APLT stock under the Base Case scenario is 6.71 USD.

Is APLT stock undervalued or overvalued?

Compared to the current market price of 9.625 USD, Applied Therapeutics Inc is Overvalued by 30%.

Back to Top